基本信息
浏览量:423
职业迁徙
个人简介
I have been actively involved in the development and validation of novel imaging probes and have also pioeered the development of radionuclide therapy in Australia, especially the use of Sr-89, I-131 MIBG, I-131 rituxan, In-111 octreotide, Lu-177 octreotate and Lu177 PSMA. The treatment of neuroendocrine tumours and neuroblastoma are of particular interest to me. My clinical activities are underpinned by a strong interest in fundamental and translational research. I am passionate about advocacy on behalf of patients with rare cancers who are discriminated against by a system that values large industry-funded studies in common cancers above personalised medicine based on unique characterisation of the patient and their disease.
Specialties: Molecular Imaging and Radionuclide Therapy
Specialties: Molecular Imaging and Radionuclide Therapy
研究兴趣
论文共 882 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
JOURNAL OF NEUROENDOCRINOLOGYno. 1 (2024)
PET CLINICSno. 2 (2024): 291-306
Biomedical physics & engineering expressno. 2 (2024)
Journal of Neuroendocrinologyno. 1 (2024)
PET clinicsno. 2 (2024): 291-306
EUROPEAN UROLOGYno. 1 (2024): 61-62
Seval Beykan Schuerrle,Uta Eberlein,Catherine Ansquer,Jean-Mathieu Beauregard,Lucie Durand-Gasselin,Henning Gronbaek,Alexander Haug,Rodney J. Hicks,Nat P. Lenzo,Shaunak Navalkissoor,Guillaume P. Nicolas, Ben Pais,
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2024)
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn